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Background: Torque Teno Virus (TTV) was the first single stranded circular DNA virus to be discovered that infects
humans. Although there have been numerous reports regarding the prevalence of TTV from other countries of
South Asia, there is severe lack of information regarding its prevalence in Pakistan. Thus the present study compiles
the first indigenous report to comprehensively illustrate the incidence of the virus in uninfected and hepatitis
infected population from Pakistan. Another aim of the study was to present the sequence of full length TTV
genome from a local isolate and compare it with the already reported genome sequences from other parts of the
world.
Methods: TTV DNA was screened in the serum of 116, 100 and 40 HBV infected, HCV infected and uninfected
individuals respectively. Nearly full length genome of TTV was cloned from a HBV patient. The genome sequence
was subjected to in-silico analysis using CLC Workbench, ClustalW, ClustalX and TreeView. Statistical analysis was
carried out in SPSS v17.0.
Results: Our results report that 89.7%, 90.0% and 92.5% of HBV, HCV patients and healthy control population were
positive for TTV infection. TTV genome of 3603 bp was also cloned from a local isolate and given the identity of
TPK01. The TTV genome sequence mentioned in this paper is submitted in the GenBank/EMBL/DDBJ under the
accession number JN980171. Phylogenetic analysis of TPK01 revealed that the Pakistani isolate has sequence
similarities with genotype 23 and 22 (Genogroup 2).
Conclusion: The results of the current study indicate that the high frequency of TTV viremia in Pakistan conforms
to the reports from other areas of the world, wherever screening of TTV DNA was performed against 50-UTR of the
genome. The high sequence diversity among TTV genome sequences and the high frequency of prevalence makes
it harder to study this virus in cellular systems.
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Torque Teno Virus (TTV) is a circular ssDNA virus [1].
It has been classified in a newly characterized genus
called Anelloviridae. The genome size of TTV varies
from 3.6-3.8 kb [2].
TTV is unique in many ways, it is the first single
stranded circular DNA virus to be discovered that
infects humans [3]. Another distinguishing property of
TTV is its small genome size for a virus that infects* Correspondence: lcianunique@yahoo.com
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reproduction in any medium, provided the orhumans. Also the nucleotide sequence variation between
genotypes of TTV is greater than 50% which explains its
distribution to at least 39 genotypes [4]. Before the dis-
covery of TTV, this high rate of mutation was never
observed in a human virus with such a small genome
size. Moreover TTV genome shows greater variation at
ORF level than in the UTRs, which is again a distinctive
trait limited to TTV and TTV-like viruses [5].
Reports regarding prevalence of TTV in blood show
immense disparity, from a viremia rate of 2-23% [6] to
its frequency in blood rising as high as 90% [7,8]. This
variation in the rate of positive detection depends on thel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Summary of TTV prevalence in different study
groups




HBV Patients 116 104(89.7%) 12(10.3%)
HCV Patients 100 90(90.0%) 10(10.0%)
Control Population 40 37(92.5%) 3(7.5%)









(N = 116) 34.1 ± 13.3 76:40 90.84 ± 47.7
TTV+ 34.1 ± 12.56 69:35 93.35 ± 48.7
TTV- 34 ± 19 7:5 61.3 ± 13.56
Hepatitis C
(N = 100) 38.72 ± 12.2 51:49 90.83 ± 40.6
TTV + 38.75 ± 11.4 42:48 90.86 ± 44.2
TTV- 38.4 ± 18.5 7:3 91.7 ± 39.2
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UTRs of the genome are more conserved as compared
to the ORFs therefore primers from UTR will cross-
match a large number of genotypes [9] and hence will
give a higher rate of detection.
The conservation of sequence in the UTRs and diver-
gence in ORFs translates to greater disparity at amino
acid level than at the nucleotide level. For instance, the
two TTV isolates SANBAN and TA278 share only 32%
sequence identity at amino acid level while the nucleo-
tide sequence of UTRs is 78% identical [10]. Protein ex-
pression of TTV indicates that three mRNAs are
encoded from the three overlapping Open Reading
Frames (ORFs) [11]. The exact function and location of
these possible protein products is still under study [12].
As TTV was discovered in a non-A-G hepatitis patient,
the prevalence of TTV has been repeatedly examined in
subjects with hepatocellular carcinoma, Hepatitis B and C
and at various stages of liver disease. Their results indicate
a high rate (>90%) of prevalence both in healthy subjects
and in patients with some form of liver disorder [13-16]. It
is this omnipresence of TTV and the relative difficulty in
propagating it in cell cultures, that makes the study of the
TTV life cycle challenging.
In relation to hepatitis, some noteworthy observations
have surfaced. In one study the histological grade score
was higher in case of HCV-TTV co-infection as com-
pared to infection with HCV only [17]. There have been
claims that TTV viral load is a significant factor for
hepatocellular carcinoma (HCC) in hepatitis C patients,
irrespective of known risk factors [18]. In another study
the examination of 25 pediatric cases revealed that chil-
dren with co-infection of HBV and TTV showed higher
histological activity index, periportal necrosis and portal
inflammation scores [19].
More than 14 years have passed since the discovery of
Torque Teno virus but the molecular pathway it follows
in the host and its pathogenic role, if any, has yet to be
uncovered. The only report regarding prevalence of the
virus in Pakistan was made by Prescott et al., in 1999 [20].
Thus the present study compiles the first indigenous report
to comprehensively illustrate the incidence of the virus in
uninfected and hepatitis infected population from Pakistan.
The genome of TTV was also cloned and sequenced. The
sequence was analyzed and annotated through in-silico
analysis and the phylogenetic relationship with other geno-
types was determined.
Results
Prevalence of TTV detection by PCR
In this study 116, 100 and 40 samples respectively, of
HBV, HCV infected and healthy individuals were
screened with primers from 5’ UTR. The results are
represented in Table 1. Average value of age and ALTlevels along with the standard deviations and the male
to female ratio of the study group are summarized in
Table 2.
Statistical Analysis proved that there was no significant
relationship between factors such as age, gender and
ALT levels of hepatitis patients and the respective preva-
lence of TTV in HBV/HCV infected and healthy popula-
tions. The p-values for each test were above 0.05 except
in case of Fisher’s exact test for relationship between
Age and TTV incidence where p-value was 0.048. Since
the other two tests (t-test and Pearson’s chi-square) gave
a value >0.05 therefore the result of Fisher’s exact was
not sufficient to prove the hypothesis.Analysis of cloned TTV genome
The nearly full length TTV genome sequenced from
Pakistan was named as TPK01 (GenBank accession
number, JN980171). TPK01 isolate was 3,603 bp in
length and had approximately 44 bp missing from the 5’
UTR and 126 bp missing from the 3’ UTR, comprising
of the GC rich region, and due to primer constraints.
TPK01 was compared against the nucleotide repository
of NCBI using Basic Local Alignment Search Tool
(BLAST) [21] which returned the highest local alignment
with isolate Kt-08f, genotype 22 (A/C No: AB054647), 90%
query sequence matched with the subject with a maximum
nucleotide identity of 77% and E-value of 0.0.
TPK01 was compared with 106 other full-length
genomes or full-length cds of TTV in order to obtain align-
ment for construction of the phylogenetic tree (Figure 1).
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isolate matched most closely to the Genogroup 2 of
TTV genotypes [22]. Other members of this group in-
clude, Kt-08f and Kt-10f from Indonesia [23], ViPi04
from Italy [24], PMV isolate from United Kingdom
[25], KAV, TTH18, TTH10, TTH21, TTH11g2, TTH6,
TTH20 isolates from Germany [26,27]. The NCBI
Accession numbers of all sequences used in the phylo-
genetic analysis are indicated in Table 3. Due to
the high sequence diversity between TTV genome
sequences reported from around the world, the
recommended method of classification is to assignFigure 1 Phylogenetic analysis of TTV TPK01 based on full-length gen
Algorithm included in the ClustalX (version 2.0.11). Bootstrap values of >90
drawn using Treeview (version 1.6.6). TPK01 (highlighted in yellow) belongsthem in broad genogroups rather than separate
genotypes [28,29].
The sequenced genome was annotated corresponding to
the highest scoring hit in BLAST results i.e. Genotype 22
isolate Kt-08f (GenBank Accession No: AB054647) [23].
The ORF numbers were assigned according to Genotype 6
isolate HEL32 (GenBank Accession No: AY666122) [11].
The demarcation of ORFs is similar to the Kt-08f isolate
except for ORF1, which in this case is interrupted by pre-
mature stop codons at two positions. This could split ORF1
into three shorter reading frames namely; ORF1a, ORF1b,
ORF1c. The pictorial view of TPK01 is given in Figure 2.ome and/or full length cds. The tree was constructed using the NJ
0 out of 1,000 replicates are shown at the branch points. The tree was
to genogroup 2. The scale bar represents a 10% genetic difference.
Table 3 Primers used for screening and cloning of TTV DNA
S.No Primer name Purpose Sequence Position Expected product size
1. T1F Screening 50–GTA AGT GCA CTT CCG AAT GGC TGA G-30 91-115 133 bp
(NG133)
2. T1R Screening 50–AGC CCG AAT TGC CCC TTG AC-30 204-223
(NG132)
3. TTF2 Cloning 50- TAT GTC GTC CAC TTC CTG GG-30 50-69 3652 bp
4. TTR2 Cloning 50- GAG GAA GGA AGT CGG CCA TTT TG-30 3684-3707
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Torque Teno Virus (TTV) was first discovered in the
blood of a post-transfusion non A-G hepatitis patient
which led to TTV being repeatedly linked as the causal fac-
tor of cryptogenic hepatitis. There have been numerous
reports about the TTV viremia in patients of Hepatitis B
and C from all over the world but there is severe lack of
data on epidemiology of TTV and its sequence analysis
from Pakistan. Therefore the present study was designed to
clarify the rate of prevalence of TTV in hepatitis infected
population vis-à-vis healthy subjects, outline a relationship
of TTV prevalence with the incidence of hepatitis and to fi-
nally analyze the full length genome sequence of TTV from
Pakistani isolate.
The findings of this study report a TTV incidence rate of
89.7%, 90.0%, 92.5% in the Hepatitis B group, Hepatitis C
group and control population respectively. Our statistical
analysis refutes the hypothesis that the frequency of TTVFigure 2 Predicted annotation of TPK01. Splice D, A1, A2, are the splice
code for the putative proteins ORF2/3, ORF2/2, ORF1/2 and ORF1/1. HVR is
circular for convenience, although the GC-rich tract is missing from the 3’-Uincidence is influenced by the factors such as age, gender
and ALT level in hepatitis patients.
The high prevalence of TTV alludes to the likelihood
of a latent, possibly lifelong infection. Some of the
patients in our study were less than 8 years of age. Our
findings are complemented by other reports of TTV in-
fection in infants and children [28,30-32] which provide
evidence that TTV is a mother-to-child transmitted
virus, as suggested by Yokozaki et al. (1999) rather than
a blood-borne virus.
In any epidemiological study of TTV prevalence with
a PCR based method, the design and target position of
primers is crucial in determining the frequency of posi-
tive detection of virus. Due to the high sequence diver-
sity among TTV genotypes it is improbable that a single
set of primers will detect all types of TTV. For this rea-
son the primers used in this study were chosen on the
basis of extensive review of data pertaining to surveys ofacceptor and donor sites. The ORF3 will be alternatively spliced to
the Hypervariable region found in TPK01. The sequence is shown as
TR.
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of multiple reports that primers from UTRs will have
greater potential to detect multiple genotypes of TTV ra-
ther than those designed against the ORFs [33,34]. The rea-
son being that there is higher sequence conservation in the
non-coding regions than in the coding regions, where in
some stretches of the UTRs more than 90% sequence iden-
tity has been observed [5,35].
Based on the above mentioned facts, for the present
study primer pair NG133/NG132 [33] was selected. A
thorough analysis of TTV detection strategies by Hu
et al. suggests that a group of four primer sets have the
ability to screen all genotypes of TTV and TTV-like
viruses except genotype 21. Of this recommended array
of primers, NG133/NG132 is a part [36].
The results of the present study are in parallel with
data published from other parts of the world. For
example, in the study mentioned above, the positive rate
of TTV detection was found to be as high as 93% with
5’-UTR primers but only 10% with primers designed from
ORF region in the healthy population of Japan. Another
study which surveyed the TTV infection across different
geographic locations (Japan, USA, Mayanmar, Korea,
Nepal, Egypt, Bolivia, Ghana) revealed the frequency of
positive result between 70-98% from UTR primers, both in
healthy and disease infected population [16]. The only
previous report of TTV infection rate from Pakistan was
made in 1999 in blood donors from Aga Khan University,
Karachi. The reported prevalence was only 16% with pri-
mers from the N22 region which belongs to the ORF1 of
TTV [20]. In separate studies from Russia, Iran, and Hong
Kong, infection rate in healthy population was 94%, 80%
and 90% respectively [7,37,38]. In contrast to the above
reports of high prevalence, TTV was observed in only 2.9%
of healthy Iranian population emphasizing the fact that
ORF primers have less conserved sequence which makes
them incapable of matching multiple genotypes [6].
The only studies where the rate of infection in healthy
population is relatively lower than our findings, when
similar primers have been used, are from India and UAE
[39,40]. In these studies nested PCR approach was fol-
lowed where NG133/NG147 were used in the first round
while NG134/NG132 amplified in the second round.
Out of 50 healthy volunteers, only 26 tested positive
which is a 52% infection rate. The same study shows that
80.6% of patients with fulminant hepatic failure and 76%
of patients with Acute Viral Hepatitis tested positive for
TTV infection. A different research that tested the
prevalence in patients on hemodialysis and healthy sub-
jects; the positive infection rate was 83% and 43% re-
spectively [41]. The study from UAE [40] reported that
97.9, 95.7% of patients with HBV and HCV tested posi-
tive for TTV infection which aligns closely with our
results of 89.7% and 90.0% of HBV and HCV patientstesting positive for TTV infection. In contrast a mere
34.9% of healthy population was found to be carrier of
TTV DNA which differs from our finding of 92.5% of
control population that was observed as TTV positive.
The possible reasons for this marked variation in the
frequency of infection in control population in our study
and the above cited reviews could be the difference in
the number of sample population, the fact that the
prevalent genogroup in these areas is different from
Pakistan or simply that TTV is more ubiquitous in Pakistan
than in other countries.
The TTV isolate cloned in our study named TPK01 has
sequence similarity spanning over most of the genome with
the previously reported genotype 22 and 23 isolates Kt-08f
and Kt-10f from Indonesia [23]. It is worth mentioning here
that the previous isolates from Pakistan which were short
clones of N22 region (200 bp approx.) belonged to geno-
type 1a in majority [20]. TPK01 also shows significant simi-
larity to the PMV isolate from United Kingdom of
genotype 17 [25]. Stretches of 5’-UTR of the PMV sequence
are up to 92% identical to TPK01. Other sequences that
show identity with TPK01 over some stretches of genome
are ViPi04, isolate from Italy [24], tth6 and tth20 isolates of
a Hodgkin’s disease patient from Germany [27]. The entries
of genome that related most closely to TPK01 were all iso-
lates belonging to genogroup 2.
The arrangement of ORFs, promoter and poly-A sites
is similar to genotype 22 and other members of group 2.
In TPK01 nt1362-1610 show no similarity with any of
the TTV genomes assembled in NCBI Nucleotide data-
base, this region corresponds to the HVR of ORF1 and
has therefore hypermutated. In a study where TTV iso-
lates were cloned from Hodgkin’s patients, the HVR
extended over nt1425-1693 and showed 80 to 99% variation
among the isolates that were cloned, whereas the overall
variation in the sequence of the cloned TTV genomes was
only 2% [27]. This high rate of variation that translates to
divergence at the amino acid level could suggest immune-
evasion by hypermutation [27,42]. Premature stop codons
have also been observed in ORF1 of our isolate which splits
the coding sequence into three shorter translation products.
The occurrence of interrupted ORF1 has been observed in
other TTV isolates as well. ORF1 splits in two potential
reading frames in isolates tth7, tt32b8, tth8 while the isolate
tth22g4 is interrupted twice which translates to three puta-
tive proteins [27]. TCHN-a, TCHN-c1, TCHN-d2, US32
also have premature stop codons which can give rise to two
translation products instead of one [43,44].
In one study, subviral molecules could be isolated
from a Hodgkin’s lymphoma cell line when it was trans-
fected with full-length TTV genomes. It was found that
additional splicing events and rearrangements within the
genome raised ORFs that could not be explained by the
parent genomic sequence. These subviral particles varied
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Similar kinds of molecules were also isolated from sera
of pregnant mothers [45]. These findings present the
question that whether the multiple genotypes and types
of TTV (Torque Teno Mini Virus, Torque Teno Midi
Virus) are due to wide intra-genomic rearrangements or
are actually separately evolved genotypes.
Conclusion
The results of this study conform to the previous find-
ings which have established the high rate of sequence
variation in TTV genotypes. These variations in se-
quence are less pronounced in the UTR, but are seen
extensively in the ORFs. This high level of sequence
divergence and lack of apparent association with any dis-
ease poses serious questions about the role of this ever-
present replicating and mutating form of virus. The
hardest of all questions is the mode of translation and
function of TTV proteins. Therefore it is inferred that
TTV presents itself ubiquitously in human population
irrespective of any disease association so far. The se-
quence variation in the genome of TTV can suggest




The study was reviewed and approved by the Ethics
Committee of Atta-ur-Rahman School of Applied Bios-
ciences, National University of Sciences and Technology,
Sector H-12 (NUST), Islamabad, Pakistan. Informed
consent from all patients and guardians of subjects
below the age of 18 was obtained before proceeding
with the study.
Blood samples were collected from subjects who came
to Diagnostic Laboratory of Atta-ur-Rahman School of
Applied Biosciences, NUST, Sector H-12, Islamabad,
Pakistan for routine testing.
Confirmation of HBV and HCV infection
The confirmation for Hepatitis B and C infection was
done first with serological testing and then the positive
results were further tested for the presence of HBV
DNA and HCV RNA. The initial confirmation of infec-
tion with HBV was carried out with KHB EIA kits for
anti-HB core, HBe/anti-HBe and HBsAg/anti-HBs
whereas HCV infection was confirmed with KHB EIA
kit for the detection of anti-HCV antibodies.
Further confirmation of HBV and HCV infection was
carried out with RoboGene HBV DNA Quantification
Kit which amplified a region of HBV surface gene while
HCV RNA Quantification Kit was used to test against
5’-UTR of HCV genome. Standard manufacturer’s proto-
col was followed in all instances.Extraction of viral DNA
DNA was extracted from both HBV/HCV infected and
uninfected control samples using NucleoSpin Blood
MACHEREY-NAGEL DNA extraction kit. The DNA
was eluted in 50 μl of Nuclease-free water.Primer designing
Screening primers
The primers for screening of TTV DNA (NG133 and
NG132 as given in Okamoto et al., 1999b, [33]) were
chosen on basis of their specificity and sensitivity of de-
tection after extensive review of literature. The primers
used in the study are listed in Table 4.
Cloning primers
Primers were designed manually for cloning of Torque
Teno virus genome. A total of 23 sequences of full-
length or nearly full-length TTV genomes retrieved from
NCBI nucleotide database were aligned in CLC Workbench
6.1.1 [51], the primers were designed from relatively con-
served portions.
Amplification of TTV DNA
In order to clone the TTV genome, the reaction mixture
constituted of 5 μl of extracted DNA, 2.5 U each of
DreamTaq Polymerase (Fermentas EP0702) and Long
PCR Enzyme Mix (Fermentas K0182), 10pmol each of
forward and reverse primer, 2 mM of dNTPs. The PCR
mixture was preheated at 95°C for 5 minutes, then run
35 cycles with these parameters: 95°C for 40 seconds,
60°C for 40 seconds, 68°C for 4 minutes, and the final
extension was at 68°C for 10 minutes in an AB-Veriti
96-well Thermocycler.
For the detection of TTV DNA in HBV/HCV infected
population and healthy controls the reaction mixture
constituted of 8 μl of extracted DNA, 1.5 U of Taq Po-
lymerase, 10 pmol of forward and reverse primer and
2 mM dNTPs. The PCR mixture was preheated at 95°C
for 3 minutes, then run 35 cycles with these parameters:
95°C for 20 seconds, 60°C for 40 seconds, 72°C for 30
seconds, and the final extension was at 72°C for 7 min-
utes in a AB-Veriti 96-well Thermocycler. With every
batch of screening reactions, a positive and negative
control was used to eliminate the chances of any false
negative results. A positive control was the serum sam-
ple which was confirmed for TTV infection after se-
quencing while the negative control is a serum sample
repeatedly tested with multiple sets of primers from vari-
ous parts of the TTV genome but returned negative re-
sult in all cases (Detail of primers is provided in
Additional file 1).
A positive result meant the amplification of a 133 bp
fragment from T1F/TIR primers. The positive and
Table 4 Accession numbers and reference of 106
sequences used in the phylogenetic tree





1. AB017610 TA278 Okamoto et al., 1998b [8]
2. AY823988 2 h Niel et al., 2005 [22]
3. AY823989 3 h Niel et al., 2005 [22]
4. AY666122 HEL32 Qiu et al., 2005 [11]
5. AB017613 TUS01 Okamoto et al., 1999c [33]
6. AF261761 PMV Hallet et al., 2000 [25]
7. AB054647 Kt-08f Muljono et al., 2001 [23]
8. AB054648 Kt-10f Muljono et al., 2001 [23]
9. AF435014 KAV Heller et al., 2001 [26]
10. GU797360 BIS8-17 Unpublished
11. DQ187006 BM1C-18 Unpublished
12. AB064595 CT23F Peng et al., 2002 [28]
13. AB064596 CT25F Peng et al., 2002 [28]
14. AB064597 CT30F Peng et al., 2002 [28]
15. AB064604 CT39F Peng et al., 2002 [28]
16. AB064598 CT43F Peng et al., 2002 [28]
17. NC014075 CT44F Peng et al., 2002 [28]
18. AF122913 GH1 Mushahwar et al., 1999 [3]
19. AF122916 JA1 Erker et al., 1999 [5]
20. AF122918 JA2b Erker et al., 1999 [5]
21. AF122917 JA4 Erker et al., 1999 [5]
22. AF122915 JA9 Erker et al., 1999 [5]
23. AF122919 JA10 Erker et al., 1999 [5]
24. AF122914.3 JA20 Erker et al., 1999 [5]
25. AB064599 JT03F Peng et al., 2002 [28]
26. AB064600 JT05F Peng et al., 2002 [28]
27. AB064601 JT14F Peng et al., 2002 [28]
28. AB064602 JT19F Peng et al., 2002 [28]
29. AB064606 JT33F Peng et al., 2002 [28]
30. NC_014076 JT34F Peng et al., 2002 [28]
31. AB064603 JT41F Peng et al., 2002 [28]
32. AY026465 L01 Liu et al., 2002 [43]
33. AY026466 L02 Liu et al., 2002 [43]
34. AF371370 L03 Liu et al., 2002 [43]
35. NC014069 NC014069 Unpublished
36. AF298585 P1C1 Unpublished
37. AB060597 SAa-01 Okamoto et al., 2001 [23]
38. AB060594 SAa-10 Okamoto et al., 2001 [23]
39. AB060593 SAa-38 Okamoto et al., 2001 [23]
40. AB060592 SAa-39 Okamoto et al., 2001 [23]
41. AB060596 SAf-09 Okamoto et al., 2001 [23]
42. AB060595 SAj-30 Okamoto et al., 2001 [23]
43. AB025946.2 SANBAN Hijikata et al., 1999 [40]
44. AM712003 Sle1931 Leppik et al., 2007 [45]
45. AM712004 Sle1932 Leppik et al., 2007 [45]
Table 4 Accession numbers and reference of 106
sequences used in the phylogenetic tree (Continued)
46. AM711976| Sle1957 Leppik et al., 2007 [45]
47. AM712030 Sle2057 Leppik et al., 2007 [45]
48. AM712031 Sle2058 Leppik et al., 2007 [45]
49. AM712033 Sle2061 Leppik et al., 2007 [45]
50. AM712034 Sle2065 Leppik et al., 2007 [45]
51. AM712032 Sle2072 Leppik et al., 2007 [45]
52. AF247138 T3PB Biagini et al., 2000
53. AF345526 TCHN-A Luo et al., 2002 [44]
54. AF348409 TCHN-B Luo et al., 2002 [44]
55. AF345523 TCHN-C1 Luo et al., 2002 [44]
56. AF345527 TCHN-C2 Luo et al., 2002 [44]
57. AF345524 TCHN-D1 Luo et al., 2002 [44]
58. AF345525 TCHN-D2 Luo et al., 2002 [44]
59. AF345522 TCHN-E Luo et al., 2002 [44]
60. AF345528 TCHN-F Luo et al., 2002 [44]
61. AF345521 TCHN-G1 Luo et al., 2002 [44]
62. AF345529 TCHN-G2 Luo et al., 2002 [44]
63. AB028668 TJN01 Ukita et al., 2000 [46]
64. AB028669 TJN02 Ukita et al., 2000 [46]
65. AJ620218 TTH3 Jelcic et al., 2004 [27]
66. AJ620226 TTH4 Jelcic et al., 2004 [27]
67. AJ620227 TTH5 Jelcic et al., 2004 [27]
68. AJ620212 TTH6 Jelcic et al., 2004 [27]
69. AJ620230 TTH7 Jelcic et al., 2004 [27]
70. AJ620231 TTH8 Jelcic et al., 2004 [27]
71. AJ620219 TTH9 Jelcic et al., 2004 [27]
72. AJ620213 TTH10 Jelcic et al., 2004 [27]
73. AJ620214 TTH11 Jelcic et al., 2004 [27]
74. AJ620232 TTH13 Jelcic et al., 2004 [27]
75. AJ620228 TTH14 Jelcic et al., 2004 [27]
76. AJ620220 TTH16 Jelcic et al., 2004 [27]
77. AJ620221 TTH17 Jelcic et al., 2004 [27]
78. AJ620215 TTH18 Jelcic et al., 2004 [27]
79. AJ620233 TTH19 Jelcic et al., 2004 [27]
80. AJ620216 TTH20 Jelcic et al., 2004 [27]
81. AJ620217 TTH21 Jelcic et al., 2004 [27]
82. AJ620234 TTH22g4 Jelcic et al., 2004 [27]
83. AJ620235 TTH23 Jelcic et al., 2004 [27]
84. AJ620222 TTH25 Jelcic et al., 2004 [27]
85. AJ620223 TTH26 Jelcic et al., 2004 [27]
86. AJ620224 TTH27 Jelcic et al., 2004 [27]
87. AJ620229 TTH29 Jelcic et al., 2004 [27]
88. AJ620225 TTH31 Jelcic et al., 2004 [27]
89. FR751471 TTV-HD14i de Villiers et al., 2011 [47]
90. FR751472 TTV-HD15a de Villiers et al., 2011 [47]
91. FR751476 TTV-HD16a de Villiers et al., 2011 [47]
92. FR751488 TTV-HD17 de Villiers et al., 2011 [47]
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93. FR751489 TTV-HD18a de Villiers et al., 2011 [47]
94. FR751491 TTV-HD19 de Villiers et al., 2011 [47]
95. FR751492 TTV-HD20a de Villiers et al., 2011 [47]
96. FR751498 TTV-HD21 de Villiers et al., 2011 [47]
97. FR751499 TTV-HD22 de Villiers et al., 2011 [47]
98. FR751500 TTV-HD23a de Villiers et al., 2011 [47]
99. FR751506 TTV-HD24a de Villiers et al., 2011 [47]
100. AB038620 TTVsan-s039 Takahashi et al., 2000 [48]
101. AB038621 TTVyon-Kc009 Takahashi et al., 2000 [48]
102. AF247137 TUPB Biagini et al., 2000 [49]
103. AB050448 TYM9 Okamoto et al., 2000 [50]
104. AF122921 US32 Erker et al., 1999 [5]
105. AF122920 US35 Erker et al., 1999 [5]
106. DQ361268 ViPi04 Maggi et al., 2006 [24]
Hussain et al. Virology Journal 2012, 9:320 Page 8 of 10
http://www.virologyj.com/content/9/1/320negative control were also loaded on gel along with the
gene ruler.
Cloning of TTV genome
Due to high sequence diversity within the TTV genome,
multiple sets of primers were used to amplify the full
length genome. The TTV genome was successfully amp-
lified from a HBV positive subject.
The gel eluted 3.6 kb amplified TTV product was
cloned in a pCR 2.1 vector using TOPO TA Cloning Kit
(Catalog no: K4500-01, Invitrogen, USA). The ligated vector
was then transformed in Top10 strain of Escherichia coli.
Recombinant plasmids were then prepared from cell cul-
tures. Initially, the plasmid was confirmed for the presence
of TTV genome insert with restriction digestion.
Sequencing
The cloned TTV genome was sequenced with M13 uni-
versal primers as well as two sets of internal primers
(Details provided in Additional file 1) using an ABI
3730×l DNA Sequencer (Biobasic Inc Canada).
In-silico analysis
Multiple genome sequences available in NCBI database
were retrieved and aligned with the local Pakistani iso-
late in CLC Workbench 6.1.1 and ClustalX, version
2.0.11 [52]. Phylogenetic tree was then constructed using
Neighbour-Joining Algorithm included in ClustalX. The
robustness of the tree was tested with bootstrapping
technique where the tree was replicated 1000 times with
a seed value of 111. TreeView, version 1.6.6 was used to
draw the final tree. The protein products from the ORFs
were predicted in CLC Workbench 6.1.1. Alignment
with pre-reported proteins was done in CLUSTALW
and CLC Workbench. Scores for amino acid identityand similarity was retrieved from SIAS (Sequences Iden-
tities and Similarities) server [53].
Statistical analysis
The prevalence data generated with the screening of
TTV DNA in HBV/HCV and healthy population was
analyzed with statistical tests carried out in SPSS, ver-
sion 17.0. The hypothesis to be tested was whether fac-
tors such as age, gender and ALT levels of hepatitis
patients affect the rate of prevalence of TTV. Student’s
t-test, Pearson’s correlation and chi-square/fisher’s exact
test were applied wherever relevant. P value <0.05 was
considered significant.
Additional file
Additional file 1: Primers used for establishing negative control
and sequencing.
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